Experts Discuss Safety, Cost-Effectiveness, Patient Outcomes for RTA IV Push Products

Published: December 3, 2023
illustration of a syringe

Are you up to date on the landscape of considerations regarding ready-to-administer (RTA) IV push products, compared with traditional IV vial products? On Monday, Dec. 1, join our expert faculty, John B. Hertig and Satya Krishna Ramachandran as they examine the holistic costs of waste, taking into account cost-effectiveness data in the selection and implementation of RTA IV push products. They’ll describe new evidence on perioperative opioid use and associated adverse clinical outcomes and share strategies for reducing product waste, organizational costs, and postoperative adverse events.

The Midday Symposium, Ready-to-Administer IV Push Products: A Multidisciplinary Approach to Safety, Cost-Effectiveness, and Patient Outcomes in Health System and Perioperative Settings, takes place from 11:30 a.m. to 1 p.m. PT in room 155, 100 Level, Anaheim Convention Center North. Earn 1.5 hours of CE credit.

The Midday Symposium will also be broadcast as a live webinar for CE credit. If you have colleagues at home who are interested in this topic, encourage them to register for the webinar.

This activity is provided by ASHP and supported by an educational grant from Fresenius Kabi USA, LLC.

Posted December 3, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information